GlassScriptPhysician profile
Jill M Hetzel
NPI 1477624526
$3,754.63
in general payments reported to CMS, 2019-2025
20 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2022: $544 · 2023: $1,470 · 2024: $1,173 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,878.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $783.92 | 2021-2024 | Airsupra, Breztri, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $606.65 | 2021-2024 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $585.20 | 2021-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $289.02 | 2022-2024 | Glassia, Hyqvia |
| Bayer Healthcare Pharmaceuticals INC. | $205.50 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $195.87 | 2021-2024 | Acthar |
| Inspire Medical Systems, INC. | $195.08 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $175.55 | 2021-2023 | Wakix |
| Jazz Pharmaceuticals INC. | $161.45 | 2021-2024 | |
| Lilly USA, LLC | $125.00 | 2025 | Zepbound |
| Pfizer INC. | $99.61 | 2022-2024 | |
| Philips North America LLC | $80.79 | 2023-2025 | (Ak6) Vest Therapy, Patient Interface Software |
| Actelion Pharmaceuticals US, INC. | $65.71 | 2022-2023 | Uptravi |
| Grifols USA, LLC | $44.46 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $35.24 | 2024 | Zerbaxa, Recarbrio, Dificid |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $33.60 | 2022 | |
| Amgen INC. | $30.03 | 2022 | |
| Corium, LLC | $16.16 | 2022 | |
| Vapotherm INC | $15.40 | 2021 | |
| Inogen, INC. | $10.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Hetzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.